Related references
Note: Only part of the references are listed.MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer
Cristina Migliore et al.
CLINICAL CANCER RESEARCH (2012)
Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer
Shu Shimada et al.
GUT (2012)
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer
Yuji Toiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Centralspindlin and α-catenin regulate Rho signalling at the epithelial zonula adherens
Aparna Ratheesh et al.
NATURE CELL BIOLOGY (2012)
Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer
Min Shi et al.
PLOS ONE (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
Mark A. Eckert et al.
CANCER CELL (2011)
Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
Francesco Galimi et al.
CLINICAL CANCER RESEARCH (2011)
Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence
Hidehiko Shimokawa et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
Jiliang Qiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process
Leonardo Freire-de-Lima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion
Gunjan Malik et al.
CANCER RESEARCH (2010)
Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia
Marie Schoumacher et al.
JOURNAL OF CELL BIOLOGY (2010)
Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients
Yi Ding et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
Ulrike Stein et al.
NATURE MEDICINE (2009)
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
Marisa G. Ponzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Shigeo Takaishi et al.
STEM CELLS (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer
Joana Simoes-Correia et al.
HUMAN MOLECULAR GENETICS (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Essential requirement for Rho family GTPase signaling in Pax3 induced mesenchymal-epithelial transition
O'Neil Wiggan et al.
CELLULAR SIGNALLING (2006)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
CD44 is required for two consecutive steps in HGF/c-Met signaling
V Orian-Rousseau et al.
GENES & DEVELOPMENT (2002)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition
GCM Zondag et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
